Technical Analysis for BLPH - Bellerophon Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 0.6991 1.32% 0.01
BLPH closed up 1.32 percent on Monday, March 18, 2019, on 24 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical BLPH trend table...

Date Alert Name Type % Chg
Mar 18 Narrow Range Bar Range Contraction 0.00%
Mar 18 Doji - Bearish? Reversal 0.00%
Mar 18 Weak + Overbought Other 0.00%
Mar 18 Weak, Overbought and Reversal Signs Reversal 0.00%
Mar 18 Overbought Stochastic Strength 0.00%
Mar 15 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.32%
Mar 15 Narrow Range Bar Range Contraction 1.32%
Mar 15 NR7 Range Contraction 1.32%
Mar 15 Weak + Overbought Other 1.32%
Mar 15 Weak, Overbought and Reversal Signs Reversal 1.32%

Older signals for BLPH ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Bellerophon Therapeutics LLC, a clinical-stage therapeutics company, focuses on the development of various products for the treatment of cardiopulmonary and cardiac diseases. Its product candidates include INOpulse for the treatment of pulmonary arterial hypertension, as well as to treat pulmonary hypertension associated with chronic obstructive pulmonary diseases; and bioabsorbable cardiac matrix, a medical device for the prevention of congestive heart failure. The company was formerly known as Ikaria Development LLC and changed its name to Bellerophon Therapeutics LLC in January 2014. Bellerophon Therapeutics LLC was founded in 2009 and is based in Hampton, New Jersey.
Cardiovascular Diseases Hypertension Pulmonary Arterial Hypertension Anatomy Heart Failure Aging Associated Diseases Cardiovascular System Pulmonology Pulmonary Hypertension Chronic Obstructive Pulmonary Diseases Congestive Heart Failure Respiratory Disease
Is BLPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.3
52 Week Low 0.47
Average Volume 406,965
200-Day Moving Average 1.2727
50-Day Moving Average 0.7389
20-Day Moving Average 0.655
10-Day Moving Average 0.6543
Average True Range 0.0419
ADX 10.79
+DI 19.543
-DI 19.9011
Chandelier Exit (Long, 3 ATRs ) 0.6043
Chandelier Exit (Short, 3 ATRs ) 0.6757
Upper Bollinger Band 0.715
Lower Bollinger Band 0.595
Percent B (%b) 0.87
BandWidth 18.320611
MACD Line -0.0112
MACD Signal Line -0.0247
MACD Histogram 0.0135
Fundamentals Value
Market Cap 24.83 Million
Num Shares 35.5 Million
EPS -1.39
Price-to-Earnings (P/E) Ratio -0.50
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.73
Resistance 3 (R3) 0.73 0.71 0.72
Resistance 2 (R2) 0.71 0.71 0.71 0.72
Resistance 1 (R1) 0.71 0.70 0.70 0.71 0.72
Pivot Point 0.69 0.69 0.69 0.69 0.69
Support 1 (S1) 0.69 0.69 0.68 0.69 0.68
Support 2 (S2) 0.67 0.68 0.67 0.68
Support 3 (S3) 0.67 0.67 0.67
Support 4 (S4) 0.67